Webinar | Artificial Intelligence| August 12, 2021

A Diagnostic and Interventional Cardiology Roundtable Webinar, September 2 at 12 ET/ 11 CT

Artificial intelligence is becoming best practice to support clinical decisions and help standardize echocardiography analysis for practices. AI, trained on millions of outcome-based data, can provide automation for operators to obtain highly accurate and precise measurements, to better detect and predict cardiovascular disease.

Artificial intelligence is becoming best practice to support clinical decisions and help standardize echocardiography analysis for practices. AI, trained on millions of outcome-based data, can provide automation for operators to obtain highly accurate and precise measurements, to better detect and predict cardiovascular disease.

REGISTER NOW

Part 1 – Patricia A. Pellikka, M.D. (Vice Chair, Department of Cardiovascular Medicine at Mayo Clinic, US)

Currently, the identification of cardiovascular diseases by echocardiography, such as heart failure with preserved ejection fraction, remains subjective and challenging. Pellikka discusses the utilization of deep-learning applications to echocardiography for the diagnostic classification of cardiovascular disease. This Includes insights into how AI applications are being used and developed for automated image quantification and prediction of heart failure and coronary artery disease.

Part 2 - Federico M. Asch, M.D. (Director of the Echocardiography Core Lab at MedStar Health Research Institute, Georgetown University, US)

The global COVID-19 pandemic has created significant burden for health care and is shown to significantly affect the heart for which echocardiography is playing an increasingly significant role. Federico Asch, M.D., discusses the results of the WASE-COVID study, a multi-center study from The World Alliance Societies of Echocardiography, comparing human vs machine learning-based echocardiography analysis applied as a predictor of outcomes in acute Covid-19 patients – and how it can be applied to help clinicians more consistently measure ejection fraction and strain.

Part 3 -  Q&A

DAIC Editor Dave Fornell hosts a Q&A session with Dr. Pellikka, Dr. Asch and Dr. Woodward, Chief Technical Officer at Ultromics, taking a closer look at the AI used in both studies and the role in clinical practice today.

Speakers

Patricia Pellikka, M.D., Vice Chair, Department of Cardiovascular Medicine, Mayo Clinic, US

Federico Asch, M.D., Director of the Echocardiography Core Lab at MedStar Health Research InstituteGeorgetown University, US

Gary Woodward, Ph.D., Chief Technical Officer, Ultromics

REGISTER NOW

UNABLE TO ATTEND THE EVENT?
Registrants will automatically receive a link to the on-demand version when available

 


Related Content

News | Artificial Intelligence

September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech ...

Home September 22, 2022
Home
News | Artificial Intelligence

September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by ...

Home September 02, 2022
Home
News | Artificial Intelligence

August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...

Home August 29, 2022
Home
News | Artificial Intelligence

August 18, 2022 — Six digital healthcare start-ups from five countries have officially become the first cohort of the ...

Home August 18, 2022
Home
News | Artificial Intelligence

August 16, 2022 — Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis ...

Home August 16, 2022
Home
News | Artificial Intelligence

August 11, 2022 — The recent deals and collaborations in the medical device space indicate a growing interest in ...

Home August 11, 2022
Home
News | Artificial Intelligence

July 25, 2022 — Blackford, the platform for medical imaging applications and AI, and Us2.ai today announced their ...

Home July 25, 2022
Home
News | Artificial Intelligence

July 19, 2022 — Employing artificial intelligence to help improve outcomes for people with cardiovascular disease is the ...

Home July 19, 2022
Home
News | Artificial Intelligence

July 14, 2022 — Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a ...

Home July 14, 2022
Home
News | Artificial Intelligence

July 7, 2022 — Anumana, Inc., an AI-driven health technology company from nference, Inc., today announced the American ...

Home July 07, 2022
Home
Subscribe Now